文献

J-GLOBAL ID：201602261818522655   整理番号：16A1380103

糖尿病性網膜症を併発した高コレステロール血症患者に対する標準的対強化的なスタチン療法(EMPATHY)研究の論拠とデザイン:無作為化比較試験

Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial

著者 (6件)： Ueshima Kenji (Department of EBM Research, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital) ,  Itoh Hiroshi (Division of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine) ,  Kanazawa Nobuaki (Shionogi & Co., Ltd.) ,  Komuro Issei (Department of Cardiovascular Medicine, The University of Tokyo Graduate School of Medicine) ,  Nagai Ryozo (Jichi Medical University) ,  Takeuchi Masahiro (Department of Clinical Medicine (Biostatistics and Pharmaceutical Medicine), School of Pharmacy, Kitasato University)
資料名： Journal of Atherosclerosis and Thrombosis (Web)  (Journal of Atherosclerosis and Thrombosis (Web))
巻： 23  号： 8  ページ： 976-990(J-STAGE)  発行年： 2016年 
JST資料番号： U0153A  ISSN： 1880-3873  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 目的:高脂血症と糖尿病性網膜症は,心血管疾患(CVD)のリス...

シソーラス用語： ヒト ,...
準シソーラス用語： スタチン療法 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1380103&from=J-GLOBAL&jstjournalNo=U0153A") }}

著者キーワード (5件)： Dyslipidemia ,  Diabetic retinopathy ,  Hydroxymethylglutaryl-CoA reductase inhibitors ,  Randomized controlled trial ,  Primary prevention

分類 (2件)： 代謝異常・栄養性疾患の治療  (GD05030F) ,  眼の疾患  (GP03000U)

引用文献 (34件)：

• 1) Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, and Simes R; Cholesterol Treatment Trialists' (CTT) Collaborators: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet, 2005; 366: 1267-1278
• 2) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 2001; 285: 2486-2497
• 3) Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, and Witztum JL: Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care, 2008; 31: 811-822
• 4) Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, and Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med, 1998; 339: 229-234
• 5) Nishimura T, Nakajima K, Kusuoka H, Yamashina A, and Nishimura S: Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study. Eur J Nucl Med Mol Imaging, 2008; 35: 319-328

タイトルに関連する用語 (10件)： 糖尿病性網膜症 ,  併発 ,  高コレステロール血症 ,  患者 ,  標準 ,  強化 ,  スタチン療法 ,  研究 ,  デザイン ,  無作為化比較試験